摘要
目的:探讨血清腺苷脱氨酶(Adenosine deaminase,ADA)、总胆汁酸(Total bilious acid,TBA)和α-L-岩藻糖苷酶(α-L-Fucosidase,AFU)联合检测对肝脏疾病的诊断价值。方法:分别测定急性肝炎组、慢性活动性肝炎组、慢性迁延性肝炎组、肝硬化组、肝癌组及健康对照组血清ADA、TBA、AFU、丙氨酸氨基转移酶(ALT)及γ-谷氨酰转移酶(γ-GT)。结果:相对于健康对照组,ADA和TBA在各型肝炎及肝硬化中均有不同程度的升高,而肝癌患者的AFU明显升高,ADA和TBA无明显升高。结论:联合检测血清ADA、TBA和AFU在肝脏疾病的诊断和鉴别诊断中具有更高价值。
Objective：To investigate the diagnostic value of combined detection of serum Adenosine deaminase（ADA）,Total bilious acid（TBA） and α-L-Fucosidase（AFU） in patients suffering from liver diseases.Methods： Serum ADA,TBA,AFU and ALT,γ-GT among actute hepatitis group,chronic active hepatitis group,chronic persistent hepatitis group,cirrhosis group,hepatic cancer and healthy contrast group were determined respectively.Results： Compared with healthy contrast group,ADA and TBA increased differently in actute hepatitis group,chronic active hepatitis group,chronic persistent hepatitis group and cirrhosis group.AFU improved significantly in the patients with hepatic cancer,but the results of ADA and TBA were similar to those of healthy controls.Conclusion： The associated tests of ADA,TBA and AFU are helpful to improve the diagnosis and differential diagnosis of liver diseases.
出处
《中国卫生检验杂志》
CAS
2011年第10期2480-2481,2484,共3页
Chinese Journal of Health Laboratory Technology
